Physician profile
Megan P Johnson
NPI 1578865952
$437.97
in general payments reported to CMS, 2019-2025
12 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $55.92 · 2023: $56.21 · 2024: $174 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $67.43 | 2024-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Axonics, INC. | $57.38 | 2022-2024 | Bulkamid |
| Astellas Pharma US INC | $45.60 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $40.13 | 2023-2025 | Cologuard Collection Kit |
| Coopersurgical, INC. | $36.50 | 2024 | Paragard T 380a, Endosee |
| Exeltis, USA INC. | $35.89 | 2023-2025 | Slynd |
| Pfizer INC. | $33.66 | 2023-2024 | |
| Organon LLC | $32.03 | 2024-2025 | Jada System |
| Sage Therapeutics, LLC | $30.94 | 2025 | Zurzuvae |
| Stryker Corporation | $22.79 | 2024 | Universal Neuro 3 |
| Janssen Biotech, INC. | $18.81 | 2025 | Tremfya |
| Bayer Healthcare Pharmaceuticals INC. | $16.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.